NDC 49035-612

equate allergy relief

Loratadine

equate allergy relief is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Wal-mart Stores Inc. The primary component is Loratadine.

Product ID49035-612_08055e95-858f-467b-bb0e-f93f6360e324
NDC49035-612
Product TypeHuman Otc Drug
Proprietary Nameequate allergy relief
Generic NameLoratadine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2007-04-27
Marketing CategoryANDA / ANDA
Application NumberANDA076301
Labeler NameWal-Mart Stores Inc
Substance NameLORATADINE
Active Ingredient Strength10 mg/1
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 49035-612-46

10 BLISTER PACK in 1 CARTON (49035-612-46) > 1 TABLET in 1 BLISTER PACK
Marketing Start Date2012-02-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 49035-612-47 [49035061247]

equate allergy relief TABLET
Marketing CategoryANDA
Application NumberANDA076301
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2012-03-01

NDC 49035-612-65 [49035061265]

equate allergy relief TABLET
Marketing CategoryANDA
Application NumberANDA076301
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2012-02-29

NDC 49035-612-87 [49035061287]

equate allergy relief TABLET
Marketing CategoryANDA
Application NumberANDA076301
Product TypeHUMAN OTC DRUG
Marketing Start Date2012-03-01

NDC 49035-612-46 [49035061246]

equate allergy relief TABLET
Marketing CategoryANDA
Application NumberANDA076301
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2012-02-28

NDC 49035-612-95 [49035061295]

equate allergy relief TABLET
Marketing CategoryANDA
Application NumberANDA076301
Product TypeHUMAN OTC DRUG
Marketing Start Date2013-08-20

NDC 49035-612-76 [49035061276]

equate allergy relief TABLET
Marketing CategoryANDA
Application NumberANDA076301
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-02-03

NDC 49035-612-72 [49035061272]

equate allergy relief TABLET
Marketing CategoryANDA
Application NumberANDA076301
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2007-04-27

Drug Details

Active Ingredients

IngredientStrength
LORATADINE10 mg/1

OpenFDA Data

SPL SET ID:dd36dc43-a9b7-4cda-86e0-9283d996a60a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 311372
  • NDC Crossover Matching brand name "equate allergy relief" or generic name "Loratadine"

    NDCBrand NameGeneric Name
    49035-200equate allergy reliefequate allergy relief
    49035-312Equate Allergy ReliefEquate Allergy Relief
    49035-458equate allergy reliefequate allergy relief
    49035-571equate allergy reliefequate allergy relief
    49035-612equate allergy reliefequate allergy relief
    49035-379equate allergy reliefequate allergy relief
    49035-366equate allergy reliefequate allergy relief
    0363-1612allergy reliefLoratadine
    0113-7612Basic Care allergy reliefLoratadine
    0113-7500basic care childrens allergy reliefloratadine
    0113-7671Basic Care Childrens Allergy ReliefLoratadine
    0121-0849Childrens LoratadineLORATADINE
    0363-2131Childrens LoratadineLoratadine
    0363-4020CHILDRENS LORATADINE ODTLoratadine
    0363-2092Childrens Wal-itinLoratadine
    0363-2108Childrens WalitinLoratadine
    0113-0612good sense allergy reliefLoratadine
    0113-1191good sense allergy reliefloratadine
    0113-1612good sense allergy reliefLoratadine
    0113-9755good sense allergy reliefloratadine
    0113-0671Good Sense childrens allergy reliefLoratadine
    0113-1019good sense childrens allergy reliefloratadine
    0113-1719good sense childrens allergy reliefLoratadine
    0363-0858Indoor Outdoor Allergy ReliefLoratadine
    0179-8317LoratadineLoratadine
    0363-0522LoratadineLoratadine
    0363-0527LoratadineLoratadine
    0363-0752LoratadineLoratadine
    0363-9603LoratadineLoratadine
    0363-0699Wal itinLoratadine
    0363-0754Wal-itinLORATADINE
    0363-1686WAL-ITINLORATADINE
    0363-9150Wal-itinLoratadine
    0363-2085Wal-itin Allergy ReliefLoratadine

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.